期刊文献+

活化T细胞核因子对组成性启动子SV40的调控作用 被引量:2

Effects of nuclear factor of activated T cells on the promoter activity of constitutively activated SV40
下载PDF
导出
摘要 目的:利用双荧光素酶报告系统探讨活化T细胞核因子(NFAT)能否调控常见组成性启动子CMV,SV40和TK,为不同条件下选择合适双荧光报告系统内参提供依据。方法:用限制性内切酶BglⅡ和HindⅢ分别从质粒pCDNA3.1和pRL-TK中切下CMV和TK启动子,克隆至pGL3-basic载体中,构建成pCMV-Luc和pTK-Luc载体。将构建pCMV-Luc和pTK-Luc以及商品化的pGL3-control(SV40启动子驱动),分别与SV40(pBIND)和TK(pRL-TK)两种启动子驱动的两种内参质粒共转染入HEK293细胞;观察过表达组成性活化NFAT后相对荧光素酶活性读数的改变。结果:成功构建了pCMV-Luc和pTK-Luc质粒,荧光素酶活性检测发现,常见组成性启动子SV40启动子对过表达组成性活化的NFAT存在一定的反应。结论:T细胞活化过程中重要的转录因子NFAT能够调控SV40启动子活性;表明常见组成性启动子SV40并非真正、绝对的组成性不变。因此,在荧光素酶报告系统内参选择时需要充分考虑该问题,本研究为合理选择内参质粒提供了一个可行策略。 AIM: To check if the common used consti- tutively promoters, such as CMV, TK and SV40 could be responded to the nuclear factor of activated T cell ( NFAT), and to explore the strategies to choose rational internal control in the dual luciferase reporter assay. METHODS: pCMV-luc vector, in which luciferase activity is driven by CMV promoter, was cloned by amplifying the CMV promoter fragment from the pCDNA3.1 vector and then inserting the CMV promoter region into the pGL3-basic vector using the standard protocol, pTK-Luc reporter was similarly construc- ted, with the TK promoter from the pRL-TK vector. The constructed pCMV-Luc or pTK-Luc was co-transfected with pBIND or pRL-TK respectively, together with NFAT or con- stitutively active form named NFATCA. Relative luciferase activity was calculated as instructed by the manual instruc- tion. RESULTS: Both pCMV-Luc and pTK-Luc vectors were successfully constructed. Luciferase activity assay revealed that SV40 promoter responded to active NFAT. CONCLU- SION: The common used internal control promoter SV40 could respond to active NFAT, which should be kept in mind for selection of the rational internal control vector in the dual luciferase reporter assay. In addition, our study here also provides a practical strategy for rational selection of the internal control.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第5期452-454,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(31100979)
关键词 活化T细胞核因子 双荧光素酶报告系统 组成性启动子 内参 nuclear factor of activated T cell Dual lucifer-ase reporter assay constitutively activatedpromoter internal control
  • 相关文献

参考文献9

  • 1Muller MR, Rao A. NFAT, immunity and cancer : a transcription fac- tor comes of age[Jl. Nat Rev Immunol, 2010, 10(9) : 645 -656.
  • 2Lee JY, Kim S, Hwang do W, et al. Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis and postt- ranscriptional regulation[J]. J Nucl Med, 2008, 49(2) : 285 -294.
  • 3Dyer BW, Ferrer FA, Klinedinst DK, et al. A noncommercial dual luciferase enzyme assay system for reporter gene analysis [ J ]. Anal Biochem, 2000, 15 ; 282(1 ) : 158 - 161.
  • 4Yang G, Yu F, Fu H, et al. Identification of the distinct promoters for the two transcripts of apoptosis related protein 3 and their transcription- al regulation by NFAT and NFKB[J]. Mol Cell Biochem, 2007, 302 (1-2) : 187 -194.
  • 5Girardi C, De Pitta C, Casara S, et al. Analysis of miRNA and mR- NA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity [ J/OL]. PLoS One, 2012, 7(2) : e31293.
  • 6Lerner M, Lundgren J, Akhoondi S, et al. MiRNA-27a controls FBW7/hCDCA-dependent cyclin E degradation and cell cycle progres- sion [J]. Cell Cycle, 2011, 10(13): 2172-2183.
  • 7Dar AA, Majid S, de Semir D, et al. miRNA-205 suppresses melano- ma cell proliferation and induces senescence via regulation of E2F1 protein[ J]. J BM Chem, 2011, 286 (19) : 16606 - 16614.
  • 8Kastl L, Brown I, Schofield AC. miRNA-34a is associated with docetaxel resistance in human breast cancer cells [ J ]. Breast Cancer Res Treat, 2012, 131(2): 445-454.
  • 9Zhou R, Hu G, Gong AY, et al. Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transaetivation of miRNA genes in human biliary epithelial cells [ J ]. Nucleic Acids Res, 2010, 38(10): 3222-3232.

同被引文献22

  • 1李杰,张福城,王文泉,黄丽云.高等植物启动子的研究进展[J].生物技术通讯,2006,17(4):658-661. 被引量:46
  • 2Borden EC, Sen GC, Uze G, et al. Interfemns at age 50: past, current and future impact on biomedicine[J]. Nat Rev Drug Discov, 2007, 6(12) : 975 -990.
  • 3Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling [J]. Ann N Y Acad Sci, 2008, 1143:1 -20.
  • 4Kuga T, Fujita T, Taniguchi T. Nucleotide sequence of the mouse interferen-beta gene [ J/OL ]. Nucleic Acids Res, 1989, 17 ( 8 ) : 3291.
  • 5Gonzalez-Navajas JM, Lee J, David M, et al. Immunomodulatory functions of type I interfemns[ J]. Nat Rev Immunol, 2012, 12(2) : 125 - 135.
  • 6Eisenacher K, Krug A. Regulation of RLR-mediated innate immune sigualing-it is all about keeping the balance [ J ]. Eur J Cell Biol, 2012, 91(1) : 36 -47.
  • 7Isaacs A, Lindenmann J. Vires interference. I. The interferon[ J]. Pmc R Soc Lend B Biol Sci, 1957, 147(927) : 258 -267.
  • 8Pestka S, Krause CD, Waiter MR. Interferons, interfemn-hke cytokines, and their receptors[J]. Immunol Rev, 2004, 202:8-32.
  • 9Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R [ J ]. Nat Immunol, 2003, 4 ( 1 ) : 63 - 68.
  • 10Crotta S, Davidson S, Mahlakoiv T, et al. Type I and type Ill interferoos drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia [ J/OA ]. PLoS Pathog, 2013, 9(11) : e1003773.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部